| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/04/2006 | US7071202 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071200 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/04/2006 | US7071198 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma |
| 07/04/2006 | US7071197 N,N-disubstituted diazocycloalkanes |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
| 07/04/2006 | US7071194 Amyotrophic lateral sclerosis; administering serotonin receptors antagonist |
| 07/04/2006 | US7071193 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071190 Substituted thieno(3,2-d)pyrimidines, such as N-(2-Methoxy-ethyl)-2-(6-(3,5-dimethylphenyl))thieno(3,2-d)pyrimidinyl-4-yl)-hydrazine; treating proliferative diseases such as cancer |
| 07/04/2006 | US7071189 Heterocyclic compounds as antitumor agents with benzimidazole group and morpholine group, triazoline or pyrimidine heterocycles |
| 07/04/2006 | US7071188 Synergistic mixture of metalaxyl, fludioxonil and strobilurin |
| 07/04/2006 | US7071187 Naphthyridine derivatives |
| 07/04/2006 | US7071185 Treating schizophrenia with no weight-gain side effects; 5-HT2c recptor agonist; bipolar disorder; antidepressants; anxiolytic agents; panic attack; agoraphobia; antiepileptic agents; sleep disorders; migraines; sexual dysfunction |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071183 Use of inhibitors of the renin-angiotensin system |
| 07/04/2006 | US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 07/04/2006 | US7071181 Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| 07/04/2006 | US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 07/04/2006 | US7071179 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 07/04/2006 | US7071178 Bone disorders; osteoporosis |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 07/04/2006 | US7071176 Aryl phosphate derivatives of AZT having anti-HIV activity |
| 07/04/2006 | US7071175 Pyridine mercapto carboxylic acids as carboxypeptidase U inhibitors |
| 07/04/2006 | US7071174 Method and composition for inhibiting cholesterol esterase |
| 07/04/2006 | US7071173 Human t-cell,lymphocyte virus; hepatitis virus |
| 07/04/2006 | US7071172 Secretion signal vectors |
| 07/04/2006 | US7071170 Bactericides; antiprotozoa agents |
| 07/04/2006 | US7071167 Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines |
| 07/04/2006 | US7071165 LHRH antagonist peptides |
| 07/04/2006 | US7071158 Antioxidant enhancement of therapy for hyperproliferative conditions |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070968 DNA damaging agents in combination with tyrosine kinase inhibitors |
| 07/04/2006 | US7070942 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 07/04/2006 | US7070815 Anti diarrhoea compositions |
| 07/04/2006 | US7070814 Plant extracts for treatment of cancer |
| 07/04/2006 | US7070812 Process for producing dry powders of one or more carotenoids |
| 07/04/2006 | US7070811 Directly compressible formulations of azithromycin |
| 07/04/2006 | US7070809 Hydrogel biomedical articles |
| 07/04/2006 | US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness |
| 07/04/2006 | US7070804 Vitamin tablet enhancing appetite and calcium absorption |
| 07/04/2006 | US7070803 Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine |
| 07/04/2006 | US7070800 Inhalable powder containing tiotropium |
| 07/04/2006 | US7070797 Administration of a G1 and/or S phase drug, which is preferably beta-lapachone, or a derivative or analog thereof, combined with a G2/M phase drug such as a taxane derivative, which is advantageously paclitaxel. |
| 07/04/2006 | US7070778 treating breast concer by administering a monoclonal antibody with an oligo- beta -(1,3)-glucan and a carrier |
| 07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
| 07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
| 07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
| 07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
| 07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
| 07/04/2006 | US7070759 High dose radionuclide complexes for bone marrow suppression |
| 07/04/2006 | CA2462452C Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| 07/04/2006 | CA2404848C Indole carboxylic acids as thyroid receptor ligands |
| 07/04/2006 | CA2396674C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2344318C Methods for administration of antibiotics |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 07/04/2006 | CA2279063C A pharmaceutical composition for the prevention and treatment of diseases of cognitive dysfunction in a mammal |
| 07/04/2006 | CA2264721C A1 adenosine receptor antagonists |
| 07/04/2006 | CA2250840C Antivirally active heterocyclic azahexane derivatives |
| 07/04/2006 | CA2247329C Composition containing antitumor agent |
| 07/04/2006 | CA2233285C Pyrazolopyrimidines as crf receptor antagonists |
| 07/04/2006 | CA2228956C Cdna corresponding to the antigenome of nonsegmented negative strand rna viruses, and process for the production of such viruses encoding additional antigenically active proteins |
| 07/04/2006 | CA2200579C Phenyl-oxo-alkyl-(4-piperidinyl)benzoate derivatives as colon motility enhancing agents |
| 07/04/2006 | CA2159419C Solid pharmaceutical composition comprising an excipient capable of binding water |
| 07/04/2006 | CA2130797C 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity, and synthesis of .alpha.-substituted-arylacetamides |
| 06/29/2006 | WO2006069395A2 Synthetic process for the preparation of biocyclic compounds |
| 06/29/2006 | WO2006069329A2 Therapy inhalation involving antisense oligonucleotides for treating idiopathic pulmonary fibrosis |
| 06/29/2006 | WO2006069326A2 Polyethylene glycolated superoxide dismutase mimetics |
| 06/29/2006 | WO2006069294A1 1-aminocyclohexane-derivatives for the treatment of multiple sclerosis emotional lability and pseudobulbar affect |
| 06/29/2006 | WO2006069293A2 Composition comprising n-acetylcysteine and further pain or anti- inflamm medications |
| 06/29/2006 | WO2006069277A1 TRICYCLIC δ-OPIOID MODULATORS |
| 06/29/2006 | WO2006069276A2 TRICYCLIC ō-OPIOID MODULATORS |
| 06/29/2006 | WO2006069275A1 Tricyclic delta-opioid modulators |
| 06/29/2006 | WO2006069258A1 Substituted heterocyclic compounds and methods of use |
| 06/29/2006 | WO2006069224A2 Improved citral and citronellal derivatives |
| 06/29/2006 | WO2006069213A1 Pharmaceutical formulations |
| 06/29/2006 | WO2006069208A2 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 06/29/2006 | WO2006069196A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 06/29/2006 | WO2006069193A2 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 06/29/2006 | WO2006069186A2 Small molecule bcl-xl/bcl-2 binding inhibitors |
| 06/29/2006 | WO2006069175A2 Antifungal properties of various forms of sophorolipids |
| 06/29/2006 | WO2006069162A1 Novel heterocyclic compounds and their pharmaceutical compositions |
| 06/29/2006 | WO2006069159A2 Pharmaceutical compositions comprising amorphous benzimidazole compounds |
| 06/29/2006 | WO2006069153A2 Vitamin d receptor modulators |
| 06/29/2006 | WO2006069125A1 Indazole-carboxamide compounds |
| 06/29/2006 | WO2006069098A1 Nanoparticulate bicalutamide formulations |
| 06/29/2006 | WO2006069097A2 Nicotinic alpha-7 receptor ligands and preparation and uses thereof |
| 06/29/2006 | WO2006069080A2 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2m3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 06/29/2006 | WO2006069063A1 Pyrrolidine inhibitors of iap |
| 06/29/2006 | WO2006068992A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006068991A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006068988A1 Combination therapy for vascular complications associated with hyperglycemia |
| 06/29/2006 | WO2006068973A2 Methods for use of oral care compositions containing free-b-ring flavonoid anti-oxidants |
| 06/29/2006 | WO2006068933A2 Mitotic kinesin inhibitors |
| 06/29/2006 | WO2006068932A2 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |